Past Events

  • Read more: Trauma at the Border
    Mar 4 2019

    Trauma at the Border

    Recording

    Description At the center of contemporary political debate are the record numbers of migrant families and children at the U.S.-Mexico border. As these parents and children flee the trauma of violence in their native countries, they are now experiencing the trauma of navigating an increasingly hostile immigration system. What can neuroscience tell us about the…

  • Read more: Accelerating Alternatives to Animal Experimentation
    Mar 1 2019

    Accelerating Alternatives to Animal Experimentation

    This panel gave an overview of the current state of developing alternatives to animal use in science and research, before then discussing whether an “accelerator” type business model could be used to explore and invest in alternatives potentially leading to life-saving improvements for both people and animals. This event was free and open to the…

  • Read more: Inequity in Mental Health Care Access
    Feb 20 2019

    Inequity in Mental Health Care Access

    This panel discussed the many local and national hurdles to mental health care access and equity. How do the barriers to mental health care impact people of different backgrounds and socioeconomic status? What can local, state, or national governments do to reduce the disparities in mental health care outcomes? How can lawyers help reduce these…

  • Read more: Black-Box Medicine: Legal and Ethical Issues: A Health Policy and Bioethics Consortium
    Feb 8 2019

    Black-Box Medicine: Legal and Ethical Issues: A Health Policy and Bioethics Consortium

    Recording

    Description Black-box medicine—the use of opaque computational models to make care decisions—has the potential to shape health care by improving and aiding many medical tasks. For example, IBM Watson for Oncology is a machine-learning system that intends to help clinicians quickly identify essential information in patients’ medical records and explore treatment options for 13 cancers.…

  • Read more: When is a Medical Treatment Worth $850,000? The Value of Luxturna and Gene Therapy Treatments: A Health Policy and Bioethics Consortium
    Dec 14 2018

    When is a Medical Treatment Worth $850,000? The Value of Luxturna and Gene Therapy Treatments: A Health Policy and Bioethics Consortium

    Luxturna, a gene therapy treatment for a rare form of inherited blindness, was recently approved and administered for the first time to a patient at Massachusetts Eye and Ear in early 2018 at a cost of $850,000. How should patients, physicians, and the U.S. health care system approach a new generation of gene therapies that…

  • Read more: Seventh Annual Health Law Year in P/Review
    Dec 7 2018

    Seventh Annual Health Law Year in P/Review

    Recording

    Description At the Seventh Annual Health Law Year in P/Review symposium, leading experts discussed major developments during 2018 and what to watch out for in 2019. Speakers covered hot topics including health policy under the current administration, pharmaceutical policy, and public health law. Featured panels explored “Challenges Facing Health Care General Counsels” and “AI in…

  • Read more: Health Law Workshop: James Hodge
    Dec 3 2018

    Health Law Workshop: James Hodge

    Presentation Readings Include From The Presenter ​Please note that the readings for the upcoming session are presented as a trilogy of short essays published in the Journal of Law, Medicine, and Ethics on the session topic. Together, these essays provide a concise illustration of the concept of constitutional cohesion and its expressions through multiple interpretations,…

  • Read more: Simulation and Deliberation to Prepare for Clinical Trials in Infectious Disease Emergencies: Digital Health @ Harvard Series
    Nov 27 2018

    Simulation and Deliberation to Prepare for Clinical Trials in Infectious Disease Emergencies: Digital Health @ Harvard Series

    Recording

    Description Infectious disease emergencies are opportunities to test the efficacy of newly developed interventions (e.g. drugs, vaccines and treatment regimens), yet they raise many intertwined challenges of politics, logistics, ethics, and study design. Consistent with the efforts of CEPI, WHO, and others to encourage development and Phase I/II testing of candidate vaccines (the focus of…

  • Read more: Health Law Workshop: Craig Konnoth
    Nov 26 2018

    Health Law Workshop: Craig Konnoth

    Presentation Download the Presentation: “Medical Civil Rights” About the Presenter Craig Konnoth is Associate Professor of Law at Colorado Law. His work lies at the intersection of health law and policy, bioethics, civil rights, and technology. His papers consider how health privacy burdens are created and distributed, how medical discourse is used both to enable…

  • Read more: Health Law Workshop: Anya Prince
    Nov 19 2018

    Health Law Workshop: Anya Prince

    Presentation Topic: “Gene Therapy’s Field of Dreams: If You Build It, Will We Pay?” This paper is not available for download. To request a copy in preparation for the workshop, please contact Jennifer Minnich at jminnich@law.harvard.edu. About the Presenter Anya Prince is Associate Professor of Law at the University of Iowa College of Law and…